Biolinq develops a wearable biosensor platform that is capable of measuring blood level information. Under the leadership of Jared Tangney and Josh Windmiller, Biolinq is redefining how biomedical innovations can be imagined and commercialized. While conducting his post-doctoral research at the University of California, San Diego in the laboratoryfor NanoBioElectronics, Josh saw the potential to bring nanotechnology to the medical world. Combining forces with Jared, a Ph.D. in Biomedical Engineering, the two saw the opportunity to bring their minimally-invasive technology to the diabetes space. Finally, people with diabetes will have a better CGM experience that is not only more affordable but also pain-free.

Health Care

Biotechnology

Biolinq

Richard Yang

Patrick McBride

Sam Marsh

David de Renzy

Brian L.

Lev Kurbanyan

Anderson Micu

David Arida

Todd Newhouse

Sky Christopherson

Rebecca Gottlieb

Powell Zhang

M. Andrew (Drew) Woodmansee

Kristie Kinch

James Galloway

David Carner

Arlene Doria

Ajay Padsalgikar

Amy VandenBerg

Kate Hunter

Eric Ferrer

Alan Campbell

Naresh Bhavaraju

Tom Peyser

Jared Tangney

Research and Development

Engineering and Development

Engineering Team

Corporate Operations

Leadership Team

Research and Development Team

Clinical and Regulatory Affairs Team

Teams at Biolinq